Here’s the announcement
CannTrust Holdings Inc. (“CannTrust” or the “Company”) announces it is re-entering the Canadian medical cannabis market today with its new medical brand estoraTM and will begin serving patients immediately.
estoraTM builds on CannTrust’s foundation of consistent, high quality products, with a focus on providing superior patient care in every interaction, connecting patients, health care practitioners and partners with the educational resources and products they need to navigate each patient’s unique medical cannabis journey.
“Since our inception, we have been dedicated to providing Canadians with consistently high-quality medical cannabis,” said Greg Guyatt, Chief Executive Officer at CannTrust. “We’re delighted to be launching our new medical brand estoraTM with a portfolio of medical cannabis products including oil drops, capsules and dried flower formats.”
Many products are available for sale immediately through the newly launched ecommerce site www.estoramedical.com.
“We believe it was imperative to evolve our strong foundation in medical cannabis to meet the changing needs of our patients,” said Guyatt. “estora has patient care at its core. We consulted patients and health care practitioners, learning more about their needs and refining our processes and product offerings to elevate their experience with us.”